MAPT and Alzheimer disease: Given these differences, the tau and atrophy clusters unsurprisingly showed limited overlap, suggesting that the heterogeneity in tau PET and structural MRI patterns might represent substantially different disease processes such as differential roles of comorbid non–AD pathological changes, i.e., aging, vascular pathologies, α-synuclein, and TDP-4325,29.